Trial Profile
Prospective confirmatory trial to determine the recurrence rates of pruritus after cessation of nalfurafine hydrochloride in chronic liver disease
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Sep 2018
Price :
$35
*
At a glance
- Drugs Nalfurafine (Primary)
- Indications Liver disorders
- Focus Therapeutic Use
- 25 Sep 2018 New trial record
- 01 Sep 2018 Results published in the Hepatology Research